Your SlideShare is downloading. ×
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide
  • electromyogram (EMG)
  • Transcript

    • 1. Stress Disorders, Sleep Disorders
    • 2. Stress Disorders
      • Stress (response) : physiological and behavioural reaction caused by the perception of aversive or threatening stimuli (Cannon, 1921).
      • Stressors : Environmental triggers of stress
      • PTSD requires an identifiable stressor for diagnosis
      • Often the association between the stressor and the stress response is not clear
    • 3. Stress Response
      • Fight or flight response: mobilization of resources to prepare us to face stressors
        • Effects of the Hypothalamic-Pituitary-Adrenal axis
      • Mobilization of energy in face of the stressors includes:
      • Activation of sympathetic nervous system
        • increased heart rate, increased muscular contractions, increased blood pressure, decreased digestion/metabolism
      • Adrenal hormones are released
        • Epinephrine
        • Norepinephrine (activation of NE receptors in brain)
        • Steroid stress hormones (cortisol)
    • 4. Stress Response
      • 1. Norepinephrine
        • Stressful situations (e.g. social isolation in rats) will increase release of NE
        • hypothalamus, frontal cortex, and lateral basal forebrain including portions of amygdala (Yokoo et al., 1990, Cenci et al., 1992; van Bockstaele et al., 2001)
        • Downregulation of the alpha-2 receptor in response to hight NE levels
      • 2. Serotonin
        • 5HT is decreased
        • Raphe nucleus, frontal areas involved in extinction
    • 5. Stress Response
      • 3. Glucocorticoids and corticotropin releasing hormone (CRH)
      • Receptors throughout the brain (and rest of body)
      • Controlled by the hypothalamus, CRH serves as a neuromodulator in the limbic system, periaqueductal gray matter, locus coeruleus, and amygdala
      • Injection of CRH into rats’ brains induces fear reactions (Britton et al., 1982)
      • Antagonists of CRH reduce anxiety caused by stressors (Heinrichs et al., 1994)
      • Heightened activation of sympathetic nervous system
    • 6. 1. Sufficient sensory information is present for assessment. Vermetten & Bremmer, 2002
    • 7. 2. Assessment based on access to prior experience. Vermetten & Bremmer, 2002
    • 8. 3. Encode memory of (potential) threat. Vermetten & Bremmer, 2002
    • 9. 4. Access to neuroendocrine, autonomic, motor responses. Vermetten & Bremmer, 2002
    • 10. PTSD: Prevalence, Info
      • Prevalence: 5-10% (U.S), higher in war-torn areas
      • Three themes of PTSD:
      • Re-experiencing of stressful event
      • Avoidance of stimuli
      • Persistent, increased arousal
    • 11. PTSD: Prevalence, Info
      • In adults, traumatic events occur more often to men, but PTSD is 4 times more common in women (Fullerton et al., 2001)
      • In children:
      • Loss of acquired language skills
      • Regression of toilet training
      • Somatic complaints (stomachaches or headaches)
      • Delayed onset of PTSD often occurs for chronic abuse
    • 12. PTSD: DSM-IV Criteria
      • The person has been exposed to a traumatic event in which both of the following have been present:
      • (1) the person experienced, witnessed, or was confronted with an event or events that involved actual or threatened death or serious injury, or a threat to the physical integrity of self or others
      • (2) the person's response involved intense fear, helplessness, or horror.
      • Note: In children, this may be expressed instead by disorganized or agitated behavior.
    • 13. PTSD: DSM-IV Criteria
      • B. The traumatic event is persistently re-experienced in one (or more) of the following ways:
      • recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions.
      • Note: In young children, repetitive play may occur in which themes or aspects of the trauma are expressed.
      • (2) recurrent distressing dreams of the event.
      • Note: In children, there may be frightening dreams without recognizable content.
    • 14. PTSD: DSM-IV Criteria
      • (3) acting or feeling as if the traumatic event were recurring
      • sense of reliving the experience
      • illusions, hallucinations, and dissociative flashback episodes
      • young children: trauma-specific reenactment may occur.
      • (4) intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event.
      • (5) physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event.
    • 15. PTSD: DSM-IV Criteria
      • C. Persistent avoidance of stimuli associated with the trauma and numbing of general responsiveness (three or more of the following):
      • (1) efforts to avoid thoughts, feelings, or conversations associated with the trauma
      • (2) efforts to avoid activities, places, or people that arouse recollections of the trauma
      • (3) inability to recall an important aspect of the trauma
      • (4) markedly diminished interest or participation in significant activities
    • 16. PTSD: DSM-IV Criteria
      • (5) feeling of detachment or estrangement from others
      • (6) restricted range of affect
      • unable to have loving feelings
      • (7) sense of a foreshortened future
      • does not expect to have a career, marriage, children, or a normal life span
    • 17. PTSD: DSM-IV Criteria
      • D. Persistent symptoms of increased arousal (not present before the trauma), as indicated by two (or more) of the following:
      • (1) difficulty falling or staying asleep
      • (2) irritability or outbursts of anger
      • (3) difficulty concentrating
      • (4) hypervigilance
      • (5) exaggerated startle response
    • 18. PTSD: DSM-IV Criteria
      • E. Duration of the disturbance is more than one month.
      • F. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
      • Specify if:
      • Acute: if duration of symptoms is less than 3 months
      • Chronic: if duration of symptoms is 3 months or more
      • Specify if:
      • With Delayed Onset: if onset of symptoms is at least 6 month
    • 19. Health effects of long term stress
      • Chronic stress is thought to be most problematic for long-term health
      • Acute traumatic stress , in a few cases, may be equally as devastating
      • (e.g. war, natural disasters, rape, witnessing murder)
        • Exacerbation of initial traumatic event
    • 20. Health effects of long term stress
      • Selye (1976) – long-term effects of stress are caused by chronic release of glucocorticoids
        • Increased blood pressure
        • Damage to muscle tissue
        • Steroid diabetes
        • Infertility
        • Inhibition of growth
        • Inhibition of inflammatory responses
        • Suppression of immune system
      • Loss of brain tissue
        • Elevated levels of CRH in women and men with PTSD (Yehuda, 2001)
    • 21. Neuropathology
      • volume loss of hippocampus in veterans with combat-induced PTSD (Bremner et al., 1995)
      • brain degeneration occurred in people who had been subjected to torture (Jensen et al., 1982) – note: not by experimenters
      • Loss is proportional to amount of combat exposure (Gurvits et al. 1996)
      • Similar effects in those exposed to severe childhood abuse (Bremner et al, 1999)
    • 22. Sleep Disorders
    • 23. Sleep Disorders
      • 1 in 8 Canadians suffer from a Sleep Disorder
      • May or may not be related to stress
      • May be related to undersleeping or oversleeping
      • Often comorbid with anxiety or depression
      • No age limits for definition
      • Often undiagnosed or untreated for years
      • Can have profound impact on physical and mental health
    • 24. What is normal sleep?
      • Waking
      • Beta waves: 13-40 Hz, low amplitude, asynchronous
      • Alpha waves: 8-13 Hz, higher amplitude (when meditative or relaxed).
      • 2. Stages 1 and 2 (Light sleep)
      • Theta waves: 4-7 Hz
      • May not be aware that you fell asleep
      • 3. Stages 3 and 4 (Heavy sleep)
      • Delta waves: < 4Hz
      • Sleep walking and talking
    • 25. What is normal sleep?
      • 4. Rapid eye movement (REM) sleep
      • Return of alpha and beta activity, like waking states
      • Darting eye movements
      • Dramatic loss of muscle tone--effectively paralyzed
      • Dreaming
      • Stage 1 to REM = 90 minutes
      • As night progresses, amount of REM sleep increases and stage 3-4 sleep decreases
    • 26. What is normal sleep?
    • 27. Disorders of sleep
      • Insomnia
      • Narcolepsy
      • REM Sleep Behaviour Disorder
      • Problems associated with slow wave sleep
      • Inability to sleep at night produces many of the same symptoms as the stress response--sleep is critical for neural “recovery”
      • Hallmark of all sleep disorders is an inability to maintain normal wakefulness during the day: Excessive daytime sleepiness (EDS)
    • 28. Insomnia
      • Feeling that you are not getting enough sleep, often associated with anxiety
      • May be difficulty falling asleep or early waking, often associated with depression
      • Hard to define as people differ in sleep needs
      • Often treated with drugs although majority of patients do not undergo a sleep study
      • Most drugs are barbiturates which affect GABA receptors (perhaps in reticular activating formation)
    • 29. Narcolepsy
      • Neurological disorder characterized by sleep at inappropriate times (sleep attack)
        • Overwhelming urge to sleep particularly in monotonous conditions
        • Sleep appears normal and lasts 2-5 minutes
        • Person (temporarily) feels refreshed
      • Cataplexy : muscular paralysis while fully awake (similar to paralysis during REM)
        • Usually triggered by strong emotion or sudden physical effort
      • Hypnagogic hallucinations: seeing and hearing things as one is falling asleep.
      • Often skip slow wave sleep at night and move directly to REM from waking
      • Caused by low levels or absence of a peptide hypocretin in lateral hypothalamus (Saper et al., 2001)
    • 30. REM Sleep Behaviour Disorder
      • Typically we are paralyzed during REM sleep
      • In some people, this paralysis does not occur, and they act out their dreams without awareness
      • Not necessarily the same as sleepwalking, although this may be a component
      • Associated with neurodegenerative disorders (such as Parkinson’s)
      • Can be associated with brain damage to pons, reticular activating formation (Culebras and Moore, 1989)
      • Symptoms are opposite to those of cataplexy
    • 31. Slow-wave sleep
      • Usually occur during stage 4, when a person is difficult to rouse but not dreaming
      • Include:
        • Bedwetting (nocturnal enuresis)
        • Sleepwalking (somnambulism)
        • Night terrors (pavor nocturnis)
      • All of these tend to occur more frequently in children – they usually grow out of these
      • No association with other mental health disorders
      • Not sure of neurobiology as it is difficult to do sleep studies with children
    • 32. Neuropathology
      • Wake-sleep cycles are regulated by brainstem structures
      • Thalamic nuclei (which receive direct visual input from the LGN)
      • Suprachiasmatic nucleus: circadian clock
      • Ventrolateral preoptic nucleus: wakefulness and vigilance
      • 2. Other areas
      • Raphe nucleus (pons): general arousal
      • Locus coeruleus: vigilance, arousal
    • 33. Neuropathology
      • A host of different medications are used to increase vigilance and altertness
      • Epinephrine and its agonists
      • Other monoaminergic agonists: Methylphenidate
      • Acetylcholine antagonists: Caffeine
      • Most medications with sedative effects focus on increasing GABA concentrations (benzodiazepines, barbiturates)